🦊/Investors

Mountain Group CapitalFull Portfolio

38 tracked investments · listed companies and verified rows first

AN2 Therapeuticsan2therapeutics.cominNASDAQ: ANTXSeries A · Mar 2026 · $12M

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.

BiotechHealthtechMenlo Park, US

Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Sanjay Chanda(Chief Development Officer)inLucy O. Day(Chief Financial Officer)in

Co-investorsAdjuvant CapitalBioRock VenturesFlucas VenturesRA CapitalBiotechnology Value FundHatteras Venture Partners

Castle Biosciencescastlebiosciences.comin𝕏NASDAQ: CSTL

Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.

BiotechDigital HealthHealthtechFriendswood, US

Derek Maetzold(Executive Officer, Director)inDerek J. Maetzold(President, CEO and Director)inFrank Stokes(Chief Financial Officer)inKristen Oelschlager(Chief Operating Officer)inToby Juvenal(Chief Commercial Officer)inHillary Caruso(Chief of Staff)in

Co-investorsBioBritIllumina VenturesSofinnova HealthQuest Partners

Corcept Therapeuticscorcept.cominNASDAQ: CORT

Corcept develops cortisol modulators — molecules that regulate cortisol activity at the glucocorticoid receptor — to treat serious diseases across endocrinology, oncology, metabolism, and neurology.

AI & Machine LearningBiotechHealthtechMedical Devices

Joseph K. Belanoff(Chief Executive Officer and President)

Co-investorsLongitude Capital

5Metis5metis.comin

5Metis is a discovery-stage company developing boron-based molecules for crop protection, running medicinal/discovery chemistry and toxicity testing programs to invent new agricultural active ingredients.

AgTechBiotechNew MaterialsResearch Triangle Park, US

Brian Green(Co-founder, CEO & CSO)inRichard Gianni(Executive Officer)Steve Tuttle(COO & Board Member)in

BoardYogesh Mago(Director)Cindy Smith(Director)Roger Kemble(Director)

Co-investors1855 Capital PartnersOspraie Ag Science

Advanced Animal Diagnosticsqscoutlab.comin𝕏May 2021 · $7M

QScout Lab provides rapid, on-farm diagnostic tests for livestock producers to detect diseases and guide treatment decisions.

AgTechMedical Devices

Co-investorsWolfpack Investor NetworkMiddleland Capital

Airvetairvet.comSeries B · May 2023 · $18M

Beverly Hills, US

Brandon Werber(Executive Officer, Director)inEliyahu Ben-Ezra(Executive Officer)Roy Rubin(Director)Asher Leids(Director)

BoardWilliam Su(Director)David Shadpour(Director)

Co-investorsCanvas VenturesHawke VenturesHeadlinePath VenturesStarting Line75 & Sunny+4 more

AngelEye Healthangeleye.health

Neonatal and pediatric family support technology company

HealthtechNashville, US

Christopher Rand(Executive Officer, Director)Curtis Lowery(Director)

BoardEmily Rash(Director)Alex Whitmore(Director)Gerard Hayden, Jr.(Director)Byron Smith(Director)in

Co-investorsSeedToB

Appello Pharmaceuticalsappellopharma.comSeries A · Jan 2022 · $16M

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesNashville, US

Dr. Laden(Co-founder)Christopher Rand(Executive Officer)Vaughn Bryson(Director)Jeff P. Conn(Director)

BoardWilliam Slattery(Director)Howie Furst(Director)in

Co-investorsRelevance VenturesDeerfield Management Company

Aspire Healthaspirehealthcare.cominacquired by CareMore Health (Anthem) · Jun 2018

Nashville-based provider of home and outpatient community-based palliative care for seriously ill patients, acquired by Anthem in 2018.

Digital HealthHealthtechNashville, US

Brad Smith(Executive Officer, Director)Andrew Lasher(Executive Officer)Diane Seloff(Executive Officer)William Anderson(Executive Officer)inWilliam Frist(Director)in

BoardAnn Lamont(Director)in

Co-investorsBlue Venture FundsFrist Cressey VenturesGV (Google Ventures)Lifeforce CapitalOak HC/FTSandbox Industries

Circular Genomicscirculargenomics.comin𝕏Series A · Jan 2024 · $8M

Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.

AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US

Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)

Co-investorsCottonwood Technology FundTramway Venture Partners

Clearside Biomedicalclearsidebio.comin

Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.

BiotechHealthtechMedical DevicesAlpharetta, US

Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in

BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in

Co-investorsHEALTHCARE ROYALTY PARTNERSSolasta VenturesHatterasHatteras Venture Partners

Contego Medicalcontegomedical.comin

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Co-investorsHatteras Venture PartnersLightstone VenturesAmzak HealthUS Venture Partners

Ethosethossystems.comin𝕏

Ethos Systems provides an AI-driven training platform that delivers personalized, role-specific learning content and ties training to performance data for readiness measurement.

AI & Machine LearningDefense TechEdTech

Andrew Powell(Founder)inSasha Seymore(Founder)in

Co-investorsDorm RoomJ4 VenturesMVP VenturesNorwest Venture PartnersTech Square VenturesCubit Capital

EvermindinMay 2013

Nashville, US

David A. Gilbert(Executive Officer, Director)Paul Griffin(Executive Officer)Don Stratton(Executive Officer)

BoardChristopher Rand(Director)Jeff Landman(Director)Michael Burcham(Director)

Exubrionsynovetin.comin𝕏

Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals.

BiotechHealthtechMedical Devices

G1 Therapeuticsg1therapeutics.comFeb 2015

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

BiotechResearch Triangle Park, US

Jay Strum(Executive Officer)Norman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)

Co-investorsLumira VenturesRA CapitalSolasta VenturesHatteras Venture Partners

In the Bowl Animal Healthinthebowlah.cominJun 2024

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.

BiotechConsumerFoodTechHealthtechNashville, US

Randolph Legg(Chief Executive Officer)inScott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)

Co-investorsBioBrit

Ironwood Pharmaceuticalsironwoodpharma.comin𝕏Sep 2016

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.

BiotechDigital HealthHealthtechCambridge, US

PETER M. HECHT(Executive Officer, Director)inMARK G. CURRIE(Executive Officer)inHALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)in

BoardTERRANCE G. MCGUIRE(Director)

Co-investorsF-Prime CapitalRidgeback CapitalVenrockMaverick VenturesPolaris Partners

LineaGenlineagen.comin𝕏Jan 2015

Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications.

BiotechDigital HealthHealthtechMedical DevicesSalt Lake City, US

Gayland Moffat(Executive Officer)Michael S. Paul(Executive Officer, Director)

BoardMichael Fitzgerald(Director)Fred A. Middleton(Director)Mary C. Tanner(Director)Michael Walsh(Director)

Mindera Healthminderahealth.comin𝕏

Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology.

AI & Machine LearningBiotechDigital HealthMedical DevicesVista, US

Tahir Mahmood(Executive Officer, Director)inPhilippe ` Nore(Executive Officer, Director)

BoardAndrew Offer(Director)inTyler Whitmore(Director)inJoseph C. Cook III(Director)Patrick Rivelli(Director)

Co-investorsScientific Health Development

Nusirt Sciencesnusirt.com

NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension.

BiotechHealthtechLongevityNashville, US

Michael Zemel(Executive Officer, Director)Barbara Cannon(Executive Officer)Joseph C. Cook, Jr.(Executive Officer, Director)

BoardEric Satz(Director)Vaughn Bryson(Director)Brian Laden(Director)

Co-investorsHatteras Venture Partners

PhaseBio Pharmaceuticalsphasebio.com

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Chief Executive Officer)in

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Co-investorsNew Enterprise Associates (NEA)Hatteras Venture PartnersJohnson & Johnson Innovation – JJDC

PinkDxpinkdx.comin𝕏Series A · Sep 2023 · $40M

PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.

BiotechDigital HealthFemTechIndianapolis, US

Richard T. Kloos(Chief Medical Officer)inTimothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Co-Founder and Chief Scientific Officer)Isaac Ro(Director)inRisa Stack(Director)inEric Wang(Executive Officer)

Co-investorsBEVCBlue Venture FundsSandbox Industries

ReVIDA Recovery Centersrevidarecovery.comin

ReVIDA Recovery operates a network of outpatient recovery centers that treat opioid use disorder using Medication Assisted Treatment (MAT) and a multi-disciplinary behavioral healthcare approach.

Digital HealthHealthtechMental HealthNortheast Tennessee, US

Silicon Ranchsiliconranch.cominDec 2020 · $230M

Swap Robotics builds 100% electric autonomous robots for utility-scale solar sites, handling vegetation management, solar panel laying during construction, and materials movement.

CleantechClimate TechEnergyRoboticsNashville, US

Matthew Beasley(Executive Officer, Director)Philip Bredesen(Director)inDavid Reagan Farr(Executive Officer, Director)Matthew H. Kisber(Executive Officer, Director)Michael Payne(Executive Officer)inPhilip N. Bredesen(Director)in

Co-investorsManulife Investment Management

Targantargan.comin𝕏Series A · Mar 2019 · $8M

TARGAN is an animal agtech systems company that engineers precision technologies for commercial food producers, with a focus on sustainability and animal welfare.

AgTechAI & Machine LearningFoodTechHardwareRaleigh, US

Ramin Karimpour(Founder)in

Co-investorsOval Park CapitalNovaQuest Capital Management, L.L.C.

Value Payment Systemsvaluepaymentsystems.comin𝕏

Value Payment Systems (operating as Catalis) provides payment processing and collection solutions for government agencies and public sector organizations including courts, tax offices, utilities, and child support agencies.

FintechGovTechSaaSNashville, US

Verilityverilityco.comin

Verility builds Fertile-Eyez, an AI-based image analysis and optical sensor platform for point-of-care fertility testing in animals, assessing sperm quality and predicting ovulation phase.

AgTechAI & Machine LearningHardwareHealthtech

Liane Hart(CEO & Co-Founder)inHadi Shafiee(Inventor, Co-Founder, & Technical Advisor)Brian Kopp(CFO & Head of Business Strategy)inScott Baxter(Chief Product Officer)in

Vets First Choicevetsfirstchoice.comin

Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.

HealthtechMedical DevicesSaaS

Co-investorsHarbor Light Capital PartnersBorealis VenturesClayton Dubilier & RiceHLM Venture PartnersRock Springs CapitalSequoia Heritage+1 more

Vytellevytelle.comin

Vytelle offers an integrated technology platform for cattle producers to accelerate genetic progress and enable individual animal management.

AgTechBiotechFoodTechSaaSLenexa, US

Kerryann Kocher(Executive Officer, Director)inRudy Leemans(Executive Officer)in

BoardDuane Cantrell(outgoing director)inJim Schultz(Director)Robin Readnour(Director)James (Jim) Shafter(outgoing director)

Co-investorsFulcrum Global CapitalKCRise FundSerra Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Angel Eye HealthBorahCerebrotechMiNDERA CorporationNeuroTronikOverdogReactive BioVelo-1

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.